86 related articles for article (PubMed ID: 8344991)
1. Modulation of the immunophenotype of ovarian cancer cells by N,N-dimethylformamide and transforming growth factor-beta 1.
Grunt TW; Oeller H; Somay C; Dittrich E; Fazeny B; Mannhalter C; Dittrich C
J Cell Physiol; 1993 Aug; 156(2):358-66. PubMed ID: 8344991
[TBL] [Abstract][Full Text] [Related]
2. The differential effects of N,N-dimethylformamide and transforming growth factor-beta 1 on a human ovarian cancer cell line (HOC-7).
Grunt TW; Somay C; Ellinger A; Pavelka M; Dittrich E; Dittrich C
J Cell Physiol; 1992 Apr; 151(1):13-22. PubMed ID: 1560038
[TBL] [Abstract][Full Text] [Related]
3. Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-beta binding to a human colon carcinoma cell line.
Levine AE; Black B; Brattain MG
J Cell Physiol; 1989 Mar; 138(3):459-66. PubMed ID: 2925796
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells.
Zipfel PA; Ziober BL; Morris SL; Mulder KM
Cell Growth Differ; 1993 Aug; 4(8):637-45. PubMed ID: 8398905
[TBL] [Abstract][Full Text] [Related]
5. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta].
Li Y; Chen N; Yu HJ; Dong XP; Huang QH
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
Evangelou A; Jindal SK; Brown TJ; Letarte M
Cancer Res; 2000 Feb; 60(4):929-35. PubMed ID: 10706107
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta1 up-regulates paxillin protein expression in malignant astrocytoma cells: requirement for a fibronectin substrate.
Han X; Stewart JE; Bellis SL; Benveniste EN; Ding Q; Tachibana K; Grammer JR; Gladson CL
Oncogene; 2001 Nov; 20(55):7976-86. PubMed ID: 11753680
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta modulation of the epidermal growth factor Ca2+ signal and c-Fos oncoprotein levels in A431 human epidermoid carcinoma cells.
Elliget KA; Phelps PC; Smith MW
Cell Growth Differ; 1996 Apr; 7(4):461-8. PubMed ID: 9052987
[TBL] [Abstract][Full Text] [Related]
9. Role of transforming growth factor-beta in transdifferentiation and fibrosis of lens epithelial cells.
Lee EH; Joo CK
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2025-32. PubMed ID: 10440257
[TBL] [Abstract][Full Text] [Related]
10. Fibronectin fibrils and growth factors stimulate anchorage-independent growth of a murine mammary carcinoma.
Saulnier R; Bhardwaj B; Klassen J; Leopold D; Rahimi N; Tremblay E; Mosher D; Elliott B
Exp Cell Res; 1996 Feb; 222(2):360-9. PubMed ID: 8598224
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta negatively modulates proliferation and c-fos expression of the human endometrial adenocarcinoma cell line HEC-1-A.
Bergman CA; Talavera F; Christman GM; Baker VV; Roberts JA; Menon KM
Gynecol Oncol; 1997 Apr; 65(1):63-8. PubMed ID: 9103392
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta2-induced myofibroblastic differentiation of human retinal pigment epithelial cells: regulation by extracellular matrix proteins and hepatocyte growth factor.
Gamulescu MA; Chen Y; He S; Spee C; Jin M; Ryan SJ; Hinton DR
Exp Eye Res; 2006 Jul; 83(1):212-22. PubMed ID: 16563380
[TBL] [Abstract][Full Text] [Related]
13. Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions.
Berger DH; O'Mahony CA; Sheng H; Shao J; Albo D; DuBois RN; Beauchamp RD
Surgery; 2003 May; 133(5):568-79. PubMed ID: 12773985
[TBL] [Abstract][Full Text] [Related]
14. N,N-dimethylformamide-induced synthesis of an anti-fibronectin reactive protein in cultured human colon carcinoma cells.
Marks ME; Ziober BL; Brattain MG
Cancer Res; 1986 Oct; 46(10):5248-58. PubMed ID: 3756877
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta is an endogenous radioresistance factor in the esophageal adenocarcinoma cell line OE-33.
Kim AH; Lebman DA; Dietz CM; Snyder SR; Eley KW; Chung TD
Int J Oncol; 2003 Dec; 23(6):1593-9. PubMed ID: 14612931
[TBL] [Abstract][Full Text] [Related]
16. Synergistic enhancement of EGF, but not HGF, stimulated hepatocyte motility by TGF-beta 1 in vitro.
Stolz DB; Michalopoulos GK
J Cell Physiol; 1997 Jan; 170(1):57-68. PubMed ID: 9012785
[TBL] [Abstract][Full Text] [Related]
17. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.
Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T
Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta stimulates the expression of desmosomal proteins in bronchial epithelial cells.
Yoshida M; Romberger DJ; Illig MG; Takizawa H; Sacco O; Spurzem JR; Sisson JH; Rennard SI; Beckmann JD
Am J Respir Cell Mol Biol; 1992 Apr; 6(4):439-45. PubMed ID: 1550689
[TBL] [Abstract][Full Text] [Related]
19. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association.
Ellerbroek SM; Halbleib JM; Benavidez M; Warmka JK; Wattenberg EV; Stack MS; Hudson LG
Cancer Res; 2001 Mar; 61(5):1855-61. PubMed ID: 11280738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
